Clinical Trial Update: Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

View source ↗

Summary

A multicenter study is underway to validate an AI-based ECG platform for the early diagnosis of transthyretin cardiac amyloidosis. The trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Cardiac Amyloidosis

Snippet

Sponsor: Idoven 1903 S.L. | Conditions: Transthyretin Cardiac Amyloidosis | Status: RECRUITING